Nicole Kiweler has been announced as the recipient of an EACR-Boehringer Ingelheim Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe.
Having begun her Fellowship on 04 October 2024, Nicole recently caught up with us to let us know how she feels about receiving this funding, “I am deeply honoured to have been awarded the EACR-Boehringer Ingelheim Fellowship that will greatly support my work on cancer metabolism and its implications in metastatic disease progression. The fellowship presents the excellent opportunity to further broaden my previous findings using new, targeted metabolic inhibitors of Boehringer Ingelheim and further define their potential use as therapeutic interventions.”
Nicole will give a talk on her research in the Award Winners’ session at the EACR 2025 Congress.
About the Recipient
Nicole Kiweler is a Scientist in the Cancer Metabolism Group at the Department of Cancer Research of the Luxembourg Institute of Health (LIH) where she studies cancer metabolism and its relevance for metastasis.
She completed her Diploma studies in Chemistry at the Technical University of Kaiserslautern in Germany with excellence and moved on to pursue a PhD at the Institute of Toxicology at the University Medical Centre in Mainz. Here she extended her knowledge in biochemistry to the field of cancer biology and studied the relevance of histone deacetylases for DNA repair and cancer metastasis.
After her PhD, she continued her research as a Postdoctoral Fellow at the Luxembourg Institute of Health. She began to study cancer metabolism in the context of metastatic disease and was awarded a DFG Walter Benjamin fellowship to pursue her new research focus.
Her current research focuses on defining and exploiting metabolic bottlenecks that can be targeted to prevent or diminish metastatic disease progression during standard chemotherapy. For this, she uses state-of-the-art metabolic measurements in vitro and in vivo combined with molecular biology techniques to understand the impact of the combination of targeted metabolic interventions with standard chemotherapeutic drugs on the migration, invasion and metastasis of breast cancer cells.
Click here to see Nicole Kiweler’s institute profile page
EACR Postdoctoral Fellowships
To find out more about the EACR’s other Postdoctoral Fellowships, click here.
